価格表

在庫・価格 : 2024年05月23日 18時16分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Chemerin, Human, ELISA Kit (96well)
データシート
RD191136200R BLMバイオベンダー ラボラトリー
BioVendor Laboratory Medicine, Inc.
1 kit ¥120,000
(未発注)
追加

在庫・価格 : 2024年05月23日 18時16分 現在

Chemerin, Human, ELISA Kit (96well)

  • 商品コード:RD191136200R
  • メーカー:BLM
  • 包装:1kit
  • 価格: ¥120,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Stejskal D et al. Chemerin is an independent marker of the metabolic syndrome in a Caucasian population--a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2008 Dec;152(2):217-21
Stejskal D et al
2008/01/01
PubMed
2 Sell H et al. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 2009 Dec;58(12):2731-40
Sell H et al
2009/01/01
PubMed
3 Pfau D et al. Serum levels of the adipokine chemerin in relation to renal function. Diabetes Care 2010 Jan;33(1):171-3
Pfau D et al
2010/01/01
PubMed
4 Ress C et al. Effect of bariatric surgery on circulating chemerin levels. Eur. J. Clin. Invest. 2010 Mar;40(3):277-80
Ress C et al
2010/01/01
PubMed
5 Sell H et al. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J. Clin. Endocrinol. Metab. 2010 Jun;95(6):2892-6
Sell H et al
2010/01/01
PubMed
6 Pfau D et al. Circulating levels of the adipokine chemerin in gestational diabetes mellitus. Horm Res Paediatr 2010;74(1):56-61
Pfau D et al
2010/01/01
PubMed
7 Kl旦ting N et al. Insulin-sensitive obesity. Am. J. Physiol. Endocrinol. Metab. 2010 Sep;299(3):E506-15
Kl旦ting N et al
2010/01/01
PubMed
8 T旦njes A et al. Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS ONE 2010;5(11):e13911
T旦njes A et al
2010/01/01
PubMed
9 Aronis KN et al. Chemerin levels as predictor of acute coronary events: a case-control study nested within the veterans affairs normative aging study. Metab. Clin. Exp. 2014 Jun;63(6):760-6
Aronis KN et al
2014/01/01
PubMed
10 Chakaroun R et al. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metab. Clin. Exp. 2012 May;61(5):706-14
Chakaroun R et al
2012/01/01
PubMed
11 Chamberland JP et al. Chemerin is expressed mainly in pancreas and liver, is regulated by energy deprivation, and lacks day/night variation in humans. Eur. J. Endocrinol. 2013 Oct;169(4):453-62
Chamberland JP et al
2013/01/01
PubMed
12 Coimbra S et al. Adiponectin, leptin, and chemerin in elderly patients with type 2 diabetes mellitus: a close linkage with obesity and length of the disease. Biomed Res Int 2014;2014:701915
Coimbra S et al
2014/01/01
PubMed
13 Derosa G et al. Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation. Eur J Pharm Sci 2014 Jan;51:26-33
Derosa G et al
2014/01/01
PubMed
14 Eisinger K et al. Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis. Exp. Mol. Pathol. 2012 Feb;92(1):90-6
Eisinger K et al
2012/01/01
PubMed
15 El-Mesallamy HO et al. Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabet. Med. 2011 Oct;28(10):1194-200
El-Mesallamy HO et al
2011/01/01
PubMed
16 Engin-テ徭tテシn Y et al. Postmenopausal Osteoporosis Is Associated with Serum Chemerin and Irisin but Not with Apolipoprotein M Levels. J Menopausal Med 2016 Aug;22(2):76-9
Engin-テ徭tテシn Y et al
2016/01/01
PubMed
17 Flehmig G et al. Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation. PLoS ONE 2014;9(6):e99785
Flehmig G et al
2014/01/01
PubMed
18 Ghallab NA et al. Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions. Clin Oral Investig 2017 Apr;21(3):937-947
Ghallab NA et al
2017/01/01
PubMed
19 Görkem Ü et al. Are adipokines associated with gestational diabetes mellitus? J Turk Ger Gynecol Assoc 2016;17(4):186-190
Görkem Ü et al
2016/01/01
PubMed
20 Hernández EÁ et al. Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance. J. Clin. Invest. 2017 Feb;127(2):695-708
Hernández EÁ et al
2017/01/01
PubMed
21 Horn P et al. Low circulating chemerin levels correlate with hepatic dysfunction and increased mortality in decompensated liver cirrhosis. Sci Rep 2018 Jun;8(1):9242
Horn P et al
2018/01/01
PubMed
22 Imai K et al. Impact of serum chemerin levels on liver functional reserves and platelet counts in patients with hepatocellular carcinoma. Int J Mol Sci 2014 Jun;15(7):11294-306
Imai K et al
2014/01/01
PubMed
23 Kammerer A et al. Increased circulating chemerin in patients with advanced carotid stenosis. BMC Cardiovasc Disord 2018 04;18(1):65
Kammerer A et al
2018/01/01
PubMed
24 Luque-Ram鱈rez M et al. Sexual dimorphism in adipose tissue function as evidenced by circulating adipokine concentrations in the fasting state and after an oral glucose challenge. Hum. Reprod. 2013 Jul;28(7):1908-18
Luque-Ram鱈rez M et al
2013/01/01
PubMed
25 Menzel J et al. The cross-sectional association between chemerin and bone health in peri/pre and postmenopausal women: results from the EPIC-Potsdam study. Menopause 2018 05;25(5):574-578
Menzel J et al
2018/01/01
PubMed
26 Meric M et al. Evaluation of plasma chemerin levels in patients with non-dipper blood pressure patterns. Med. Sci. Monit. 2014 Apr;20:698-705
Meric M et al
2014/01/01
PubMed
27 Neuparth MJ et al. Adipokines, oxidized low-density lipoprotein, and C-reactive protein levels in lean, overweight, and obese portuguese patients with type 2 diabetes. ISRN Obes 2013;2013:142097
Neuparth MJ et al
2013/01/01
PubMed
28 Oluwagbemigun K et al. Developmental trajectories of body mass index from childhood into late adolescence and subsequent late adolescence-young adulthood cardiometabolic risk markers. Cardiovasc Diabetol 2019 01;18(1):9
Oluwagbemigun K et al
2019/01/01
PubMed
29 Ouwens DM et al. Chemerin as biomarker for insulin sensitivity in males without typical characteristics of metabolic syndrome. Arch. Physiol. Biochem. 2012 Jul;118(3):135-8
Ouwens DM et al
2012/01/01
PubMed
30 Polyzos SA et al. Irisin in patients with nonalcoholic fatty liver disease. Metab. Clin. Exp. 2014 Feb;63(2):207-17
Polyzos SA et al
2014/01/01
PubMed
31 Reverchon M et al. Chemerin inhibits IGF-1-induced progesterone and estradiol secretion in human granulosa cells. Hum. Reprod. 2012 Jun;27(6):1790-800
Reverchon M et al
2012/01/01
PubMed
32 Saremi A et al. Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men. J Sports Sci 2010 Jul;28(9):993-8
Saremi A et al
2010/01/01
PubMed
33 Saremi A et al. Twelve-week aerobic training decreases chemerin level and improves cardiometabolic risk factors in overweight and obese men. Asian J Sports Med 2010 Sep;1(3):151-8
Saremi A et al
2010/01/01
PubMed
34 Stepan H et al. Serum levels of the adipokine chemerin are increased in preeclampsia during and 6 months after pregnancy. Regul. Pept. 2011 Jun;168(1-3):69-72
Stepan H et al
2011/01/01
PubMed
35 Waluga M et al. Serum adipokines in inflammatory bowel disease. World J. Gastroenterol. 2014 Jun;20(22):6912-7
Waluga M et al
2014/01/01
PubMed
36 Wijetunge S et al. Association between serum and adipose tissue resistin with dysglycemia in South Asian women. Nutr Diabetes 2019 Feb;9(1):5
Wijetunge S et al
2019/01/01
PubMed
37 Yilmaz Y et al. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. Atherosclerosis 2011 Jul;217(1):125-9
Yilmaz Y et al
2011/01/01
PubMed
38 Yilmaz Y et al. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. Scand. J. Gastroenterol. 2011 Jan;46(1):91-7
Yilmaz Y et al
2011/01/01
PubMed
39 Menzel J et al. Association between chemerin, omentin-1 and risk of heart failure in the population-based EPIC-Potsdam study. Sci Rep 2017 10;7(1):14171
Menzel J et al
2017/01/01
PubMed
40 Polyzos SA et al. Activin A and follistatin in patients with nonalcoholic fatty liver disease. Metab. Clin. Exp. 2016 10;65(10):1550-8
Polyzos SA et al
2016/01/01
PubMed
41 Becer E et al. Effect of the Pro12Ala Polymorphism of the Peroxisome Proliferator-activated Receptor γ2 Gene on Lipid Profile and Adipokines Levels in Obese Subjects. Balkan J. Med. Genet. 2017 Jun;20(1):71-80
Becer E et al
2017/01/01
PubMed
42 Hartl A et al. Serum levels of leptin and high molecular weight adiponectin are inversely associated with radiographic spinal progression in patients with ankylosing spondylitis: results from the ENRADAS trial. Arthritis Res. Ther. 2017 06;19(1):140
Hartl A et al
2017/01/01
PubMed
43 Diederichs T et al. Carbohydrates from Sources with a Higher Glycemic Index during Adolescence: Is Evening Rather than Morning Intake Relevant for Risk Markers of Type 2 Diabetes in Young Adulthood? Nutrients 2017 Jun;9(6)
Diederichs T et al
2017/01/01
PubMed
44 Eichelmann F et al. Methodological utility of chemerin as a novel biomarker of immunity and metabolism. Endocr Connect 2017 Jul;6(5):340-347
Eichelmann F et al
2017/01/01
PubMed
45 Waluga-Kozlowska E et al. Progranulin and chemerin plasma level in obese patients with type 2 diabetes treated with a long-acting insulin analogue and premixed insulin analogue. J Physiol Pharmacol 2021 Dec;72(6)
Waluga-Kozlowska E et al
2021/01/01
PubMed
  • No.: 1
  • 文献情報:
    Stejskal D et al. Chemerin is an independent marker of the metabolic syndrome in a Caucasian population--a pilot study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2008 Dec;152(2):217-21
    Stejskal D et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Sell H et al. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes 2009 Dec;58(12):2731-40
    Sell H et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Pfau D et al. Serum levels of the adipokine chemerin in relation to renal function. Diabetes Care 2010 Jan;33(1):171-3
    Pfau D et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Ress C et al. Effect of bariatric surgery on circulating chemerin levels. Eur. J. Clin. Invest. 2010 Mar;40(3):277-80
    Ress C et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Sell H et al. Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J. Clin. Endocrinol. Metab. 2010 Jun;95(6):2892-6
    Sell H et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Pfau D et al. Circulating levels of the adipokine chemerin in gestational diabetes mellitus. Horm Res Paediatr 2010;74(1):56-61
    Pfau D et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Kl旦ting N et al. Insulin-sensitive obesity. Am. J. Physiol. Endocrinol. Metab. 2010 Sep;299(3):E506-15
    Kl旦ting N et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    T旦njes A et al. Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes. PLoS ONE 2010;5(11):e13911
    T旦njes A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Aronis KN et al. Chemerin levels as predictor of acute coronary events: a case-control study nested within the veterans affairs normative aging study. Metab. Clin. Exp. 2014 Jun;63(6):760-6
    Aronis KN et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Chakaroun R et al. Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity. Metab. Clin. Exp. 2012 May;61(5):706-14
    Chakaroun R et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Chamberland JP et al. Chemerin is expressed mainly in pancreas and liver, is regulated by energy deprivation, and lacks day/night variation in humans. Eur. J. Endocrinol. 2013 Oct;169(4):453-62
    Chamberland JP et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Coimbra S et al. Adiponectin, leptin, and chemerin in elderly patients with type 2 diabetes mellitus: a close linkage with obesity and length of the disease. Biomed Res Int 2014;2014:701915
    Coimbra S et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Derosa G et al. Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation. Eur J Pharm Sci 2014 Jan;51:26-33
    Derosa G et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Eisinger K et al. Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis. Exp. Mol. Pathol. 2012 Feb;92(1):90-6
    Eisinger K et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    El-Mesallamy HO et al. Serum omentin-1 and chemerin levels are interrelated in patients with Type 2 diabetes mellitus with or without ischaemic heart disease. Diabet. Med. 2011 Oct;28(10):1194-200
    El-Mesallamy HO et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Engin-テ徭tテシn Y et al. Postmenopausal Osteoporosis Is Associated with Serum Chemerin and Irisin but Not with Apolipoprotein M Levels. J Menopausal Med 2016 Aug;22(2):76-9
    Engin-テ徭tテシn Y et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Flehmig G et al. Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation. PLoS ONE 2014;9(6):e99785
    Flehmig G et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Ghallab NA et al. Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions. Clin Oral Investig 2017 Apr;21(3):937-947
    Ghallab NA et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Görkem Ü et al. Are adipokines associated with gestational diabetes mellitus? J Turk Ger Gynecol Assoc 2016;17(4):186-190
    Görkem Ü et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Hernández EÁ et al. Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance. J. Clin. Invest. 2017 Feb;127(2):695-708
    Hernández EÁ et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Horn P et al. Low circulating chemerin levels correlate with hepatic dysfunction and increased mortality in decompensated liver cirrhosis. Sci Rep 2018 Jun;8(1):9242
    Horn P et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    Imai K et al. Impact of serum chemerin levels on liver functional reserves and platelet counts in patients with hepatocellular carcinoma. Int J Mol Sci 2014 Jun;15(7):11294-306
    Imai K et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Kammerer A et al. Increased circulating chemerin in patients with advanced carotid stenosis. BMC Cardiovasc Disord 2018 04;18(1):65
    Kammerer A et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Luque-Ram鱈rez M et al. Sexual dimorphism in adipose tissue function as evidenced by circulating adipokine concentrations in the fasting state and after an oral glucose challenge. Hum. Reprod. 2013 Jul;28(7):1908-18
    Luque-Ram鱈rez M et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Menzel J et al. The cross-sectional association between chemerin and bone health in peri/pre and postmenopausal women: results from the EPIC-Potsdam study. Menopause 2018 05;25(5):574-578
    Menzel J et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 26
  • 文献情報:
    Meric M et al. Evaluation of plasma chemerin levels in patients with non-dipper blood pressure patterns. Med. Sci. Monit. 2014 Apr;20:698-705
    Meric M et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 27
  • 文献情報:
    Neuparth MJ et al. Adipokines, oxidized low-density lipoprotein, and C-reactive protein levels in lean, overweight, and obese portuguese patients with type 2 diabetes. ISRN Obes 2013;2013:142097
    Neuparth MJ et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 28
  • 文献情報:
    Oluwagbemigun K et al. Developmental trajectories of body mass index from childhood into late adolescence and subsequent late adolescence-young adulthood cardiometabolic risk markers. Cardiovasc Diabetol 2019 01;18(1):9
    Oluwagbemigun K et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 29
  • 文献情報:
    Ouwens DM et al. Chemerin as biomarker for insulin sensitivity in males without typical characteristics of metabolic syndrome. Arch. Physiol. Biochem. 2012 Jul;118(3):135-8
    Ouwens DM et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 30
  • 文献情報:
    Polyzos SA et al. Irisin in patients with nonalcoholic fatty liver disease. Metab. Clin. Exp. 2014 Feb;63(2):207-17
    Polyzos SA et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 31
  • 文献情報:
    Reverchon M et al. Chemerin inhibits IGF-1-induced progesterone and estradiol secretion in human granulosa cells. Hum. Reprod. 2012 Jun;27(6):1790-800
    Reverchon M et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 32
  • 文献情報:
    Saremi A et al. Effects of aerobic training on serum omentin-1 and cardiometabolic risk factors in overweight and obese men. J Sports Sci 2010 Jul;28(9):993-8
    Saremi A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 33
  • 文献情報:
    Saremi A et al. Twelve-week aerobic training decreases chemerin level and improves cardiometabolic risk factors in overweight and obese men. Asian J Sports Med 2010 Sep;1(3):151-8
    Saremi A et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 34
  • 文献情報:
    Stepan H et al. Serum levels of the adipokine chemerin are increased in preeclampsia during and 6 months after pregnancy. Regul. Pept. 2011 Jun;168(1-3):69-72
    Stepan H et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 35
  • 文献情報:
    Waluga M et al. Serum adipokines in inflammatory bowel disease. World J. Gastroenterol. 2014 Jun;20(22):6912-7
    Waluga M et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 36
  • 文献情報:
    Wijetunge S et al. Association between serum and adipose tissue resistin with dysglycemia in South Asian women. Nutr Diabetes 2019 Feb;9(1):5
    Wijetunge S et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 37
  • 文献情報:
    Yilmaz Y et al. Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease. Atherosclerosis 2011 Jul;217(1):125-9
    Yilmaz Y et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 38
  • 文献情報:
    Yilmaz Y et al. Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease. Scand. J. Gastroenterol. 2011 Jan;46(1):91-7
    Yilmaz Y et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 39
  • 文献情報:
    Menzel J et al. Association between chemerin, omentin-1 and risk of heart failure in the population-based EPIC-Potsdam study. Sci Rep 2017 10;7(1):14171
    Menzel J et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 40
  • 文献情報:
    Polyzos SA et al. Activin A and follistatin in patients with nonalcoholic fatty liver disease. Metab. Clin. Exp. 2016 10;65(10):1550-8
    Polyzos SA et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 41
  • 文献情報:
    Becer E et al. Effect of the Pro12Ala Polymorphism of the Peroxisome Proliferator-activated Receptor γ2 Gene on Lipid Profile and Adipokines Levels in Obese Subjects. Balkan J. Med. Genet. 2017 Jun;20(1):71-80
    Becer E et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 42
  • 文献情報:
    Hartl A et al. Serum levels of leptin and high molecular weight adiponectin are inversely associated with radiographic spinal progression in patients with ankylosing spondylitis: results from the ENRADAS trial. Arthritis Res. Ther. 2017 06;19(1):140
    Hartl A et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 43
  • 文献情報:
    Diederichs T et al. Carbohydrates from Sources with a Higher Glycemic Index during Adolescence: Is Evening Rather than Morning Intake Relevant for Risk Markers of Type 2 Diabetes in Young Adulthood? Nutrients 2017 Jun;9(6)
    Diederichs T et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 44
  • 文献情報:
    Eichelmann F et al. Methodological utility of chemerin as a novel biomarker of immunity and metabolism. Endocr Connect 2017 Jul;6(5):340-347
    Eichelmann F et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 45
  • 文献情報:
    Waluga-Kozlowska E et al. Progranulin and chemerin plasma level in obese patients with type 2 diabetes treated with a long-acting insulin analogue and premixed insulin analogue. J Physiol Pharmacol 2021 Dec;72(6)
    Waluga-Kozlowska E et al
    2021/01/01
  • 備考:
  • 参照:
    PubMed